Top in cardiology: Cardiovascular safety of testosterone treatment; hands-only CPR
Click Here to Manage Email Alerts
A recent meta-analysis found no association between testosterone treatment and short- or medium-term cardiovascular risks in men with hypogonadism.
According to researchers, not enough data were gathered to draw conclusions about the relationship between testosterone treatment and long-term cardiovascular risks. It was the top story in cardiology last week.
Another top story was about the importance of bystander CPR and automated external defibrillator (AED) use during a cardiac emergency. During National CPR and AED Awareness Week, the American Heart Association promoted the use of hands-only CPR, which the organization said could increase the usage of bystander CPR and improve outcomes in patients experiencing cardiac arrest.
Read these and more top stories in cardiology below:
Meta-analysis: Testosterone treatment not linked to short-, medium-term CV events in men
In men with hypogonadism, there was no evidence that testosterone treatments cause short-term or medium-term cardiovascular risks, according to a meta-analysis published in The Lancet Healthy Longevity. Read more.
Promotion of hands-only CPR could increase usage, improve outcomes in cardiac arrest
National CPR and AED Awareness Week, initiated by the American Heart Association, the American Red Cross and the National Safety Council and designated by Congress in 2007, is held June 1 to 7 of each year. Its purpose is to highlight how lives can be saved if more Americans learn how to perform CPR and use automated external defibrillators. Read more.
Burnout, uncivil behaviors create challenges in cardiology workplaces
Building civility, respect and inclusion into the cardiology workplace is essential, especially in an era where burnout is so high, a speaker said at the National Lipid Association Scientific Sessions. Read more.
CLEAR substudies show benefit of bempedoic acid in three high-risk populations
The cholesterol benefits of Nexletol (bempedoic acid; Esperion Therapeutics) plus background therapy were consistent across subgroups of patients with hypertension, metabolic syndrome and renal impairment, researchers reported. Read more.
Statin prescriptions, LDL control low in patients before first ACS hospitalization
Fewer than 20% of patients who presented with acute coronary syndrome at a single center had LDL less than 70 mg/dL, according to data presented at the National Lipid Association Scientific Sessions. Read more.